期刊文献+

糖基化终末产物对SH-SY5Y细胞氧化应激及凋亡的影响 被引量:4

Effect of advanced glycation end products on oxidative stress and apoptosis of SH-SY5Y cells
原文传递
导出
摘要 目的研究糖基化终末产物(AGEs)对人神经母细胞瘤细胞(SH-SY5Y)凋亡的影响,探讨AGEs与阿尔茨海默病(AD)发病机制的关系。方法分别以不同浓度糖基化修饰的牛血清白蛋白(AGE-BSA)处理SH-SY5Y细胞48 h,选取AGE-BSA敏感浓度(200μg/mL)处理细胞不同时间,流式细胞仪(FCM)检测细胞凋亡率,确定AGE-BSA诱导SH-SY5Y凋亡最佳浓度及时间。将细胞随机分为对照组、牛血清白蛋白(BSA)对照组、AGE-BSA组、AGE-BSA+抗RAGE中和抗体组、AGE-BSA+α-硫辛酸组、AGE-BSA+DPI(NADPH氧化酶抑制剂)组。FCM检测细胞凋亡率变化,Hoechst 33258染色观察细胞形态改变,应用活性氧荧光探针DCFH-DA检测活性氧(ROS)水平,Western blot测定Caspase-12的表达。结果细胞凋亡率随AGE-BSA浓度增加及作用时间延长而升高,200μg/mL AGE-BSA作用48 h细胞凋亡率从对照组的(2.23±0.08)%增加到(16.8±1.27)%(P<0.05),同时,Hoechst染核后可见典型凋亡形态改变,细胞内ROS水平显著增高,Caspase-12蛋白表达明显上调,与对照组相比差异显著(P<0.05),而分别用抗RAGE中和抗体、α-硫辛酸、DPI预处理后再加入AGE-BSA,各组与AGE-BSA组比较,凋亡率明显下降,ROS水平、Caspase-12蛋白表达均明显降低(P<0.05)。结论糖基化终末产物可刺激SH-SY5Y细胞产生大量ROS及活化Caspase-12介导细胞凋亡,通过阻断其与特异性受体RAGE结合或减少细胞内ROS可减轻细胞凋亡的发生。 Objective To investigate the effect of advanced glycation end products(AGEs) on apoptosis of SH-SY5Y cells,and to further explore the relationship between AGEs and the mechanism of Alzheimer disease.Methods SH-SY5Y cells were treated with different concentrations of AGE-BSA for 48 h,or with AGE-BSA(200 μg/mL) for different times.Cell apoptosis was detected by flow cytometry(FCM) to determine the best concentration and time of AGE-BSA.SH-SY5Y cells were randomly divided into six groups: the normal control group,the BSA control group,the AGE-BSA group,the AGE-BSA+RAGE antibody group,the AGE-BSA+Alpha lipoic acid(ALA) group,and the AGE-BSA+diphenyleneiodonium(DPI) group.Cell apoptosis was detected by FCM and Hoechst staining,the level of ROS was evaluated by the 2′,7′-dichlorofluorescein diacetate(DCFH-DA) method,and expression of Caspase-12 was analyzed by Western blot.Results AGE-BSA induced SH-SY5Y cells apoptosis in a time-and concentration-dependent manner.After treatment with 200 μg/mL of AGE-BSA for 48 hours,apoptosis of SH-SY5Y cells was significantly increased to(16.8±1.27) % from(2.23±0.08)%(P0.05).Apoptosis-like cells could be found after Hoechst staining of nuclei,the level of ROS and expression of Caspase-12 statistically increased compared with the normal group(P0.05).Compared with the AGE-BSA group,apoptosis of cells,level of ROS and expression of Caspase-12 in the AGE-BSA+RAGE-Ab group,the AGE-BSA + ALA group and the AGE-BSA + DPI group were significantly decreased(P0.05).Conclusion AGEs could induce the production of ROS and activation of Caspase-12,which may be involved in apoptosis of SH-SY5Y cells induced by AGEs.Blocking the combination of AGEs and its receptor(RAGE) or reducing production of ROS may protect against AGEs-induced SH-SY5Y apoptosis.
出处 《山东大学学报(医学版)》 CAS 北大核心 2012年第1期9-14,共6页 Journal of Shandong University:Health Sciences
基金 国家自然科学基金资助项目(30971036) 山东省自然科学基金资助项目(Y2008C13)
关键词 阿尔茨海默病 糖基化终产物 高级 活性氧 CASPASE-12 细胞凋亡 Alzheimer disease Glycosylation end products advanced Reactive oxygen species Caspase-12 Apoptosis
  • 相关文献

参考文献12

  • 1Watanabe Y,Suzuki O,Haruyama T,et al.Interferon-gamma induces reactive oxygen species and endoplasmiereticulum stress at the hepatic apoptosis[J].J Cell Bio-chem,2003,89(2):244-253.
  • 2Sekido H,Suzuki T,Jomori T,et al.Reduced cell rep-lication and induction of apoptosis by advanced glycationend products in rat Schw ann cells[J].Biochem BiophysRes Commun,2004,320(1):241-248.
  • 3徐松,高顺宗,刘雪平,王美霞,董传芳,侯亮,袁树华.糖基化终末产物对人神经母细胞瘤细胞APP表达及Aβ生成的影响[J].卒中与神经疾病,2011,18(2):67-71. 被引量:4
  • 4Wautier M P,Chappey O,Corda S,et al.Activation ofNADPH oxidase by AGE links oxidant stress to alteredgene expression via RAGE[J].Am J Physiol EndocrinolMetab,2001,280(5):E685-E694.
  • 5Sasaki N,Fukatsu R,Tsuzuki K,et al.Advanced glyca-tion end products in Alzheimer's disease and other neuro-degenerative diseases[J].Am J Patllal,1998,153(4):1149-1155.
  • 6LeBlanc A C.The role of apoptotic pathways in Alzhei-mer's disease neurodegeneration and cell death[J].CurrAlzheimer Res,2005,2(4):389-402.
  • 7Yim M B,Yim H S,Lee C,et al.Protein glycation:creation of catalytic sites for free radical generation[J].Ann N Y Acad Sci,2001,928(1):48-53.
  • 8Dukic-Stefanovic S,Schinzel R,Riederer P,et al.AGESin brain ageing:AGE-inhibitors as neuroprotective andanti-dementia drugs?[J].Biogerontology,2001,2(1):19-34.
  • 9Xie Q,Khaoustov V I,Chung C C,et al.Effect of tau-roursodeoxycholic acid on endoplasmic reticulum stress-induced caspase-12 activation[J].Hepatology,2002,36(3):592-601.
  • 10Tu B P,Weissman J S.Oxidative protein folding in eu-karyotes:mechanisms and consequences[J].J Cell Bi-ol,2004,164(3):341-346.

二级参考文献16

  • 1路杰,何海.银杏叶注射液对早期糖尿病肾病患者尿微量白蛋白的影响[J].临床荟萃,2005,20(12):673-675. 被引量:6
  • 2Vitek MP,Bhattacharya K,Glendening JM,et al.Advanced glycation end products contribute to amyloidosis in Alzheimer disease.Proc Natl Acad Sci,1994,91(11):4766-4770.
  • 3Dukic-Stefanovic S,Schinzel R,Riederer P,et al.AGES in brain ageing:AGE-inhibitors as neuroprotective and anti-dementia drugs? Biogerontology,2001,2(1):19-34.
  • 4Maczurek A,Shanmugam K,Münch G.Inflammation and the redox-sensitive AGE-RAGE pathway as a therapeutic target in Alzheimer's disease.Ann N Y Acad Sci,2008,1126(1):147-151.
  • 5Mruthinti S,Sood A,Humphrey CL,et al.The induction of surface beta-amyloid binding proteins and enhanced cytotoxicity in cultured PC-12 and IMR-32 cells by advanced glycation end products.Neuroscience,2006,142(2):463-473.
  • 6Münch G,Taneli Y,Schraven E,et al.The cognition-enhancing drug tenilsetam is an inhibitor of protein crosslinking by advanced glycosylation.J Neural Transm Park Dis Dement Sect,1994,8(3):193-208.
  • 7Huang TH,Yang DS,Fraser PE,et al.Alternate Aggregation Pathways of the Alzheimer b-Amyloid Peptide.J Biol Chem,2000,275(46):36436-36440.
  • 8Hardy J,Selkoe DJ.The amyloid hypothesis of Alzheimer's disease:progress and problems on the road to therapeutics.Science,2002,297(5580):353-356.
  • 9Selkoe DJ.Alzeimer's disease:Genes,proteins,and therapy.Physiologica Reviews,2001,81(2):741-766.
  • 10Srikanth V,Maczurek A,Phan T,et al.Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease.Neurobiol Aging,(2009),doi:10.1016/j.neurobiolaging.2009.04.016.

共引文献18

同被引文献31

  • 1汪峻岭,刘瑶,郑杰.糖基化终产物对体外培养兔视网膜Müller细胞的影响[J].现代医学,2006,34(4):229-233. 被引量:2
  • 2Kahn SR. Frequency and determinants of the post thrombotic syndrome after venous thromboembolism[J]. Curr Opin Pulm Med,2006.12(5) ,299.
  • 3Deatrick KB,Eliason JL, Lynch EM, et al. Vein wall remodeling afterdeep vein thrombosiS involves matrix metalloproteinases and late fibrosis in a mouse Model[J]. J Vascsurg, 2005,42(5) :140.
  • 4Tahara N, Yamagishi S, Matsui T, et al. Serum levels of advanced glycation end products (AGEs) are independent correlates of in- sulin resistance in nondiabetic subjects[ J]. Cardiovasc Ther, 2012,30(1):42.
  • 5Ostendorp T, Leclere E,Galichet A, et al. Structural and func tional insight into RAGE activation by multimeric S100B[J]. EMBO J, 2007,26 (16) : 3868.
  • 6Shbaklo H, Holcroft CA, Kahn SR. Levels of inflammatory mark ers and the development of the post thrombotic syndrome[J]. Thromb Haemost,2009,101 ( 3 ) :505.
  • 7Deane R, Singh I, Sagare AP, et al. A multimodal RAGE speeificinhibitor reduces amyloid beta-mediated brain disorder in a mouse model of Alzheimer disease[J]. J Clin Invest, 2012,122 (4) :1377.
  • 8Kahn SR. Frequency and determinants of the post thrombotic syndrome after venous thromboembolism [ J ]. Curr Opin Pulm Med, 2006,12 (5) : 299 - 303.
  • 9Deatrick KB, Eliason JL, Lynch EM, et al. Vein wall remodeling after deep vein thrombosis invol'res matrix metalloproteinases and late fibrosis in a mouse Model[J]. J : ascsurg, 2005,42(5) :140 -148.
  • 10Tahara N, Yamagishi S, Mttsui T, et al. Serum levels of advanced glyca- tion end products (AGEs) are independent correlates of insulin resistance in nondiabetic subjects [ J ]. Cardiovasc Ther, 2012,30 ( 1 ) :42 - 48.

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部